Biofourmis Stock
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics.
Sign up today and learn more about Biofourmis Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Biofourmis Stock
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. The company discovers, develops, and delivers clinically validated software-based therapeutics to enable better outcomes for patients. These solutions include advanced tools for clinicians to deliver personalized care and cost-effective solutions for payers. Biofourmis was founded in 2015 and headquartered in Boston, Massachusetts.
Investors
Funding History
| December 2015 | $100K |
|---|---|
| August 2016 | $1.0M |
| May 2017 | $500K |
| December 2017 | $5.0M |
| May 2018 | $2.0M |
| May 2019 | $35.0M |
| September 2020 | $100M |
Management
Founder & CEO
Kuldeep Singh Rajput
CO-Founder & MD
Wendou Niu
Chief Product Officer
Sylvain Goblet
CTO
Milan Shah
COO
Jaydev Thakkar
Board Member
Anvesh Ramineni
VP, Data Science
Nandakumar Selvaraj
VP Of Software Development
Siddalingamurthy BG
Board Observer
Ryan Collins
VP, Human Resources
Andy Zucker
Chief Technology Officer
Milan Shah
Board member and Medical Advisor
Maulik Majmudar
VP Operations
Trace Brookins
Press
techinasia - Oct, 11 2023
Biofourmis to lay off 85 workers globallyprnewswire - Sep, 19 2023
Biofourmis Accelerates and Simplifies Drug Development with Expanded Digital Clinical Trials Solutionpharmaphorum - Sep, 8 2023
Biofourmis quietly parts company with CEO Rajputnews - Sep, 1 2023
The Crunchbase Tech Layoffs Trackervccircle - Aug, 31 2023
SoftBank, General Atlantic-backed Biofourmis’ founder steps down as CEOdealstreetasia - Aug, 30 2023
Healthech unicorn Biofourmis CEO steps down abruptly: reporttechinasia - Jul, 31 2023
Biofourmis cuts 120 jobs in growth-focused restructuringmobihealthnews - Jul, 25 2023
Biofourmis confirms layoffs of 120 employees globallyprnewswire - Aug, 10 2022
Biofourmis Raises Additional Funding from Intel Capital in Series D Extension and Names Top Healthcare Leaders to its Boardnews - May, 18 2022
Meet The 9 Newcomers To Join The Emerging Unicorn Board In Aprilnews - May, 11 2022
Meet The 35 Unicorns Who Joined The Board In Aprildealstreetasia - May, 5 2022
Data Vantage: Biofourmis, Voyager Innovations, HitPay receive funding and other updatesthehealthcareblog - Apr, 29 2022
#HealthTechDeals Episode 25: Biofourmis, Reify Health, Nex Health, and Amae Healthnews - Apr, 29 2022
The Week’s 10 Biggest Funding Rounds: Ad Measurement Company iSpot.tv Nabs $325M, Biofourmis Hits Unicorn Valuationtechinasia - Apr, 28 2022
Biofourmis turns unicorn after $300m series Dlnkd - Apr, 27 2022
CEO Kuldeep Singh Rajput on Biofourmis’ huge Series D raiseforbes - Apr, 26 2022
Health AI Startup Biofourmis Hits $1.3 Billion Valuation With Series D Fundingfiercehealthcare - Apr, 26 2022
Biofourmis banks $300M megaround to fuel its growth in remote care, potential M&A dealsaithority - Feb, 11 2022
Biofourmis Expands into Virtual Specialty Care with the Launch of Biofourmis Caremobihealthnews - Feb, 10 2022
Biofourmis launches virtual chronic condition management and monitoringprnewswire - Oct, 18 2021
Integra Community Care Network Partners with Biofourmis to Deliver Personalized Care at Homeprnewswire - Oct, 11 2021
Biofourmis Named 2021 DPHARM Idol Disrupt Winnerfiercebiotech - Jul, 30 2021
Biofourmis nets FDA breakthrough label for digital heart failure treatment assistantbioworld - Jul, 30 2021
Regulatory actions for July 29, 2021nanalyze - Jun, 4 2021
AI Healthcare Company Offers Software as a Medical Devicemobihealthnews - May, 26 2021
Technology's role in advancing healthcare in the homefiercebiotech - May, 12 2021
Biofourmis nabs Amazon alum to lead telehealth expansion as chief medical officerbit - Jan, 12 2021
Brigham and Women's and Biofourmis codevelop home hospital technologymedcitynews - Dec, 2 2020
Brigham and Women’s, Biofourmis launch hospital-at-home solution nationwideow - Nov, 17 2020
Weekly Refresh: Sonde Health Launched API, Akeneo’s New VP, and Moretechinasia - Nov, 8 2020
Alibaba’s big play into gamingtechinasia - Oct, 30 2020
Is Singapore medtech firm Biofourmis’ near-unicorn status warranted?cbinsights - Sep, 4 2020
This Week In AI: Microsoft Debuts Deepfake Detection Tool, Biofourmis Raises $100M, Facebook Open-Sources Differential Privacy Librarybioworld - Sep, 4 2020
Biofourmis raises $100M to expand digital care footprintbit - Sep, 4 2020
Series C funding sends Biofourmis to near-unicorn statusTechCrunch - Sep, 3 2020
SoftBank Vision Fund 2 leads $100 million Series C in digital therapeutics company Biofourmisbioworld - Aug, 1 2020
Biofourmis deploys Biovitals Sentinel platform in Singaporebit - Jul, 30 2020
Biofourmis' remote monitoring platform used by MOH for Covid-19 patientsmedcitynews - Jul, 23 2020
Chugai, Biofourmis partner on DTx for pain monitoringpharmiweb - Apr, 17 2020
Digital Therapeutics Leader Biofourmis Expands into Oncology Market with Strategic Acquisition of Gaido Healthdealstreetasia - Apr, 16 2020
SG health tech startup Biofourmis acquires Takeda’s cancer monitoring platformwsj - Mar, 5 2020
Startup Biofourmis Using AI-Based System to Battle Coronavirusxconomy - Jan, 30 2020
Biofourmis Adds Jaydev Thakkar, Milan Shah to C-Suiteasia - Dec, 26 2019
Singapore investors plow into health care startupsfiercebiotech - Nov, 19 2019
Novartis taps growing Biofourmis for digital heart failure projectdealstreetasia - Nov, 19 2019
Asia digest: Biofourmis acquires Biovotion; Funding Societies partners Carsomeprnewswire - Aug, 23 2019
Biofourmis names two pharmaceutical veterans to leadership teamforbes - May, 28 2019
25 Machine Learning Startups To Watch In 2019livemint - May, 22 2019
Sequoia leads $35 mn round in BiofourmisTechCrunch - May, 21 2019
Biofourmis raises $35M to develop smarter treatments for chronic diseasesbusinesstimes - Dec, 11 2017
Biofourmis raises US$5m in Series A funding from NSI Ventures, Aviva VenturesEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
